90%Confidence
0Views
FDASource
2026-04-16Date
Summary
Additional sterility failures for K.C. Pharmaceuticals' lubricating eye drops expands the quality control crisis to more product lines and retailers. Harris Teeter and other major distributors now face product recall and brand reputation risks.
Actionable: Investigate K.C. Pharmaceuticals' manufacturing facility compliance history and sterilization validation processes.
AI Confidence: 90%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productUltra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), Sterile, 0.5 FL OZ (15mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HEAL
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now